Here's what we know about the potentially game-changing drug right now.

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...

The growing use of GLP-1 drugs such as Wegovy and Ozempic is reducing Americans’ sugar consumption—users spend 6% less on ...

At its pharmacy, Costco now offers Ozempic and Wegovy at huge discounts, but are these GLP-1 drugs right for you?

Regeneron’s monoclonal antibody trevogrumab, with or without the anti-activin A antibody garetosmab, appears to preserve lean ...

Patients with T2D and overweight/obesity starting GLP-1 therapy may experience a small but statistically significant increase ...

More folks are using weight-loss drugs to drop pounds prior to bariatric surgery. GLP-1 drug use rose 16-fold among patients ...

New research reveals that elevated GLP-1 and its receptor contribute to brain inflammation and nausea in NMOSD, offering a ...

Novo Nordisk is well-positioned in the obesity drug market, with strong financials and anticipation for its oral Wegovy pill.

GLP-1 receptor agonists lead a new wave of therapeutic options that may benefit patients with osteoarthritis, according to ...

Affordability and access drive "gray," says Sabina Hemmi, founder of GLP Winner, a consumer watchdog. Some microdose the ...

Unusual side effects of GLP-1 drugs -- such as sagging jowls and deflated breasts -- are becoming more common, researchers ...